Related Topics News - Drugs

     
 < Previous page   Title only   |   Print    Next page > 
     
《大行》大摩降威高股份目標價至5.2港元 下調盈利預測

2026-05-06T  
《大行》大摩:上海醫藥首季業績符預期

2026-05-05T  
白雲山漢方全球招商 與多家國內外夥伴簽約戰略合作

2026-05-05T  
《大行》摩通:美眾議員要求FDA拒絕考慮中國生成臨床數據未寫入撥款法案 建議投資者不要立即採取行動

2026-05-05T  
國藥太極在研生物藥「司美格魯肽」開啟全球招商

2026-05-05T  
《大行》高盛升上海醫藥目標價至10.63元 維持「沽售」評級

2026-05-05T  
微創醫療附屬心脈醫療首季賺1.55億人民幣 增長19.4%

2026-04-29T  
《業績》上海醫藥首季歸屬淨利潤按年增長6.35%

2026-04-29T  
聯邦制藥TUL321膠囊臨床試驗申請獲FDA批准

2026-04-28T  
《業績》新華製藥首季純利跌25.2%至8,390萬人幣

2026-04-28T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.